Nicotine Content in Swedish-Type Snus Sold in Norway From 2005 to 2020
Tord Finne Vedøy1, Karl Erik Lund1
1Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, PO Box 222-Skøyen, 0213 Oslo, Norway.
Nicotine content per gram of snus increased from 2005 to 2020, but nicotine per serving remained stable. This stability in nicotine delivery is linked to a decline in loose snus market share.
Area of Science:
- Tobacco Product Analysis
- Pharmacokinetics
- Public Health
Background:
- Snus (moist smokeless tobacco) use is prevalent in Scandinavia and growing in the U.S.
- Snus products exhibit variability in nicotine content, design, and portion size.
- Previous market studies on temporal nicotine content variations in snus are limited.
Purpose of the Study:
- To analyze nicotine content variations in snus products sold in Norway between 2005 and 2020.
- To investigate changes in nicotine concentration per gram (mg/g) and per serving (mg/s).
Main Methods:
- Calculated nicotine content (mg/g and mg/s) for the top 10 snus products from major manufacturers.
- Data included nicotine, water content, and portion size for 2005, 2010, 2015, and 2020.
- Market share weighting was applied to represent overall product trends.
Main Results:
- Overall nicotine content per gram of snus increased from 16.3 to 24.1 mg/g.
- Nicotine content per serving remained stable at approximately 13.0 mg/s.
- Portion snus showed increases in both mg/g and mg/s, while loose snus saw a decrease in mg/g and stable mg/s.
Conclusions:
- Despite increased snus use, nicotine per serving remained constant.
- The stability in nicotine per serving is attributed to the reduced market share of loose snus.
- Loose snus, traditionally high in nicotine per serving, decreased from 54% in 2005 to 5% in 2020.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drug Dependence
